ArticleIntensive care medicine2018

AKI biomarkers are poor discriminants for subsequent need for renal replacement therapy, but do not disqualify them yet.

Harm-Jan de Grooth et al.PubMed ↗Publisher ↗

No numbers read from the abstract.